Correlation Between Cabio Biotech and Guangzhou Hongli

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cabio Biotech and Guangzhou Hongli at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabio Biotech and Guangzhou Hongli into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cabio Biotech Wuhan and Guangzhou Hongli Opto, you can compare the effects of market volatilities on Cabio Biotech and Guangzhou Hongli and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Guangzhou Hongli. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Guangzhou Hongli.

Diversification Opportunities for Cabio Biotech and Guangzhou Hongli

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cabio and Guangzhou is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Guangzhou Hongli Opto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guangzhou Hongli Opto and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Guangzhou Hongli. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guangzhou Hongli Opto has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Guangzhou Hongli go up and down completely randomly.

Pair Corralation between Cabio Biotech and Guangzhou Hongli

Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to generate 1.39 times more return on investment than Guangzhou Hongli. However, Cabio Biotech is 1.39 times more volatile than Guangzhou Hongli Opto. It trades about -0.06 of its potential returns per unit of risk. Guangzhou Hongli Opto is currently generating about -0.08 per unit of risk. If you would invest  2,270  in Cabio Biotech Wuhan on October 7, 2024 and sell it today you would lose (486.00) from holding Cabio Biotech Wuhan or give up 21.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cabio Biotech Wuhan  vs.  Guangzhou Hongli Opto

 Performance 
       Timeline  
Cabio Biotech Wuhan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Guangzhou Hongli Opto 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Guangzhou Hongli Opto has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cabio Biotech and Guangzhou Hongli Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cabio Biotech and Guangzhou Hongli

The main advantage of trading using opposite Cabio Biotech and Guangzhou Hongli positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Guangzhou Hongli can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guangzhou Hongli will offset losses from the drop in Guangzhou Hongli's long position.
The idea behind Cabio Biotech Wuhan and Guangzhou Hongli Opto pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume